Market Overview - The Hong Kong stock market opened slightly higher on December 4, with the Hang Seng Index at 25,804.01 points, up 43.28 points, a gain of 0.17% [10] - The Hang Seng Tech Index reported 5,552.43 points, increasing by 17.51 points, a rise of 0.32% [12] Company News - Junsheng Electronics (HK00699) has been included in the Hong Kong Stock Connect list, effective December 4, 2025, following the end of its price stabilization period in the Hong Kong market and after being listed for 10 trading days [5][14] - Junsheng Electronics' H-shares were listed on November 6 at an issue price of HKD 22, but fell to a low of HKD 14.28 before recovering to HKD 18.22 at the time of reporting [5][14] Sector Performance - The technology sector showed mixed results, with Meituan rising over 1% and Alibaba declining by 0.33% [7][15] - The innovative drug sector opened higher, with Gilead Sciences rising over 5% [7][15] - The non-ferrous metals sector saw most stocks increase, with Chalco International up over 7%, Zijin Mining and Minmetals Resources up over 4%, and Jiangxi Copper up over 3% [7][15] Market Outlook - Brokerage firms remain optimistic about the medium to long-term prospects of the Hong Kong stock market despite short-term volatility [8][15] - Short-term opportunities are seen in high dividend defensive sectors and areas supported by policy expectations [8][15] - Long-term investments are recommended in reasonably valued and fundamentally sound technology stocks, as well as potentially undervalued consumer and pharmaceutical sectors [8][15] - Positive signals to watch for include expectations of interest rate cuts by the Federal Reserve, which may improve market liquidity, along with continued inflows of southbound capital providing support [8][15]

昨日大跌12.5%的歌礼制药-B(1672.HK)反弹逾6%，现报12.64港元，总市值125.5亿港元。 消息上，歌礼制药公告显示，12月3日以每股11.680港元至12.480港元的价格回购130.60万股，回购金额达1592.75万港元。 据统计，今年以来该股累计进行29次回购，合计回购610.60万股，累计回购金额4252.64万港元。 ...

Group 1 - The Hang Seng Index opened up 0.17%, and the Hang Seng Tech Index rose by 0.21%, with the non-ferrous metals sector leading the gains, particularly Zijin Mining up 3.11% and China Aluminum up 2.77% [1] - Biotechnology stocks also saw significant increases, with Gilead Sciences rising by 3.7% and BeiGene up by 3.1% [1] - Huaxia Fund believes that the previous irrational panic in the Hong Kong tech sector has eased, and with AI development paths being pragmatic and commercialization clear, valuations are at historical lows, suggesting a potential recovery ahead of A-shares and the Hang Seng Index [1] Group 2 - CICC suggests that ahead of a significant US-China meeting, expectations of continued US easing and elevated Chinese policy expectations may support risk assets, recommending an overweight position in Chinese stocks before the meeting [1] - Guoyuan International notes uncertainty in the Fed's decision-making direction before the release of recent economic data, but the overall valuation level of Hong Kong stocks is supported by the Fed's dovish shift and the restoration of dollar liquidity after the US government reopened [1] - Zhongtai Securities sees a new cycle for coal, recommending investment opportunities in the coal sector by focusing on high dividend, low valuation stocks, and companies with significant capacity growth and profit elasticity [2]

Market Overview - US stock market continues to rise with increasing expectations of interest rate cuts, leading to a slight opening increase in Hong Kong stocks, with the Hang Seng Index up 0.17% at 25,804.01 points [1] - Major technology stocks mostly rose, with Alibaba down 0.33%, Tencent down 0.16%, JD.com up 0.61%, Xiaomi up 0.3%, NetEase up 0.32%, Meituan up 0.94%, and Kuaishou up 0.07% [1] - The innovative drug concept opened high, with Gilead Sciences up over 3% and BeiGene up 3.1% [1] - Real estate stocks were active, with China Oceanwide Holdings up over 1% [1] - The non-ferrous metals sector performed actively, with Chalco International up 7.17% and Luoyang Molybdenum up 3.43% [1] - Airline stocks opened lower, with China Eastern Airlines down over 1% [1] - Robotics concept stocks opened high, with Sanhua Intelligent Control up 5.67% and Yujian up 4.06% [1] Company News - InnoCare Pharma (02577.HK) has reached a strategic cooperation agreement with ON Semiconductor to accelerate the development of the GaN industry ecosystem [2] - The collaboration aims to integrate InnoCare's advanced GaN manufacturing capabilities with ON Semiconductor's expertise in system packaging and integration, potentially generating hundreds of millions in GaN sales over the next few years [2] - Agile Group (03383.HK) reported a total pre-sale amount of approximately 8.08 billion, a year-on-year decrease of 45.2% [3] - Jingrui Holdings (01862.HK) reported a cumulative contract sales amount of approximately 876 million, a year-on-year decrease of 54.1% [4] - China Aluminum International (02068.HK) announced that its subsidiary won a bid for a new 394,000 tons/year electrolytic aluminum project in Shanxi, with a total contract price of 3.03 billion [4] - Stone Pharmaceutical Group (01093.HK) received clinical trial approval for a selective 5-HT2A receptor agonist in the US [5] - Fosun Pharma (02196.HK) received clinical trial approval for its subsidiary's FXS887 tablets [6] - Zai Lab (02617) had its Tislelizumab tablets included in the priority review list by the National Medical Products Administration [7] - Deking Pharma (06996) received approval in Hong Kong for its Hivio® to treat two new indications: multiple myeloma and diffuse large B-cell lymphoma [7] - Kaisa Group (01813) has postponed its liquidation hearing to December 8 [8] Industry Insights - According to CCB International, domestic demand policies are being promoted, and the market is focusing on the "New Year" expectations [9] - After the consolidation in November, the Hong Kong stock market is expected to welcome a layout window for the year-end rally in December [9] - The focus is shifting from external environments to internal policies, with attention on the Central Economic Work Conference scheduled for mid-December [9] - Tianfeng Securities reported that most northern provinces have begun implementing staggered production during the heating season, with over 85% of clinker lines in a shutdown state [9] - The overall staggered production efforts have strengthened, with Hunan planning a month-long shutdown in December due to environmental pressures [9] - The bottom profitability support for cement is strong in the short term, with head enterprises starting to address overproduction capacity indicators [9]

Group 1: Economic Indicators - The US ADP employment numbers decreased by 32,000 in November, marking the lowest level since March 2023, while the market had expected an increase of 10,000 [11] - The US Treasury Secretary, Yellen, indicated that certain sectors of the economy are showing signs of weakness, suggesting a need for interest rate cuts [11] - The dollar index fell by 0.45% to 98.88, following the unexpected drop in employment data, which heightened expectations for a rate cut next week [2][6] Group 2: Market Performance - International oil prices rose, with WTI crude oil increasing by 0.84% to $59.12 per barrel and Brent crude oil rising by 0.64% to $62.78 per barrel, as investors believe that negotiations between Russia and Ukraine are unlikely to lead to the lifting of oil-related sanctions [3] - The US stock market saw the Dow Jones Industrial Average rise by 0.86%, the S&P 500 by 0.3%, and the Nasdaq by 0.17%, while Nvidia shares fell by 1% and Tesla shares rose by 4% [3] - The Hang Seng Index in Hong Kong fell by 1.28% to 25,760.73, with the technology index dropping by 1.58% [4] Group 3: Corporate Developments - Morgan Stanley maintains a bullish long-term outlook on gold, predicting prices could reach $5,000 per ounce by 2026 due to strong demand from central banks and investors [11] - The company Moer Thread is set to be listed on the STAR Market on December 5 [11] - The new stock LeMo Technology saw a first-day increase of 36.25% upon its listing [4]

Group 1: Company Announcements - JD Industrial (07618) plans to globally issue 211 million shares, with an expected listing date of December 11 [1] - China Gas (00384) adheres to its "green city operator" strategy, building a multi-energy complementary energy system and ecological collaboration, signing a strategic cooperation agreement with EVE Energy [1] - China Nuclear International (02302) indirectly controlled parent company China Uranium Industry officially listed on the Shenzhen Stock Exchange, highlighting its enhanced capital market position [1] - Innoscience (02577) and ON Semiconductor have reached a strategic cooperation agreement to accelerate the development of the gallium nitride industry ecosystem [1] - Innoscience (02577) won a lawsuit against Infineon, with the ITC ruling that the two involved patents were not infringed [1] - Wangshan Wangshui-B (02630) and Ascletis Pharma (02096) signed a licensing agreement for the new indication of VV116 [1] - China Biopharmaceutical (01177) received approval for the launch of the Rotigotine patch [1] - Dechra Pharmaceuticals-B (06996) received approval in Hong Kong for the use of Hivio® in treating multiple myeloma and diffuse large B-cell lymphoma [1] - Xianruida Medical-B (06669) received approval from the National Medical Products Administration for the registration application of the microcatheter V-otter [1] - Jiajie Ankang-B (02617) had its Tiengogatin tablets approved for inclusion in the priority review list by the National Medical Products Administration [1] - Yuexiu Transportation Infrastructure (01052) plans to acquire 85% equity of Shandong Qinbin Expressway for 1.1535 billion yuan [1] Group 2: Share Buybacks and Holdings - Tencent Holdings (00700) repurchased 1.04 million shares for 636 million HKD on December 3 [2] - Xiaomi Group-W (01810) spent approximately 302 million HKD to repurchase 7.5 million shares on December 3 [2] - Midea Group (00300) repurchased 121.27 million A-shares for 99.9984 million yuan on December 3 [2] - SF Express (06936) repurchased 163.86 million A-shares for 62.1907 million yuan on December 3 [2] - COSCO Shipping Holdings (01919) repurchased 3 million shares for 41.3725 million HKD on December 3 [2] - China Feihe (06186) repurchased 400,000 shares for 16.7927 million HKD on December 3 [2] - Galen Pharmaceuticals-B (01672) repurchased 130.6 million shares for 15.9275 million HKD on December 3 [2] - Fenbi (02469) repurchased 453.05 million shares for 14.359 million HKD on December 3 [2] - Jieli Trading Treasure (08017) saw Chairman and Executive Director Liu Yong increase holdings by 1 million shares [2] - Yiming Anke-B (01541) had Executive Director Tian Wenzhi increase holdings by 50,000 H-shares [2] - Dongfang Electric (01072) announced that Senior Vice President Wang Jun plans to reduce holdings by no more than 6,250 shares [2] - Red Star Macalline (01528) shareholder Hangzhou Haoyue plans to reduce holdings by no more than approximately 131 million shares [2] Group 3: Operating Performance - Agile Group (03383) reported a total pre-sale amount of approximately 8.08 billion yuan in the first 11 months, a year-on-year decrease of 45.2% [2]

| 2025.01.24 | 55.00 | 4.100 | 3.940 | 221.85 | | --- | --- | --- | --- | --- | | 2025.01.23 | 50.00 | 4.130 | 3.980 | 203.21 | | 2025.01.16 | 0.80 | 3.280 | 3.260 | 2.61 | | 2025.01.15 | 60.00 | 3.230 | 3.180 | 193.25 | | 2025.01.09 | 30.00 | 3.190 | 2.990 | 91.65 | | 2025.01.07 | 11.50 | 3.310 | 3.230 | 37.99 | | 2025.01.06 | 6.00 | 3.210 | 3.130 | 19.09 | | 2025.01.03 | 35.00 | 3.210 | 3.110 | 111.73 | | 2025.01.02 | 15.70 | 3.190 | 2.940 | 48.77 | 今年以来该股累计进行29次回购，合计回购610.60万股，累计回购金额4252.64万港元。（数据宝） 歌礼制药 ...

港股医药股走弱，歌礼制药-B跌超10%，圣诺医药-B跌超5%，德琪医药-B、复宏汉霖、药捷安康-B跟 跌。 ...

Key Highlights - Moer Technology is set to be listed on the Shanghai Stock Exchange's Sci-Tech Innovation Board on December 5, 2025, following approval from the Shanghai Stock Exchange [1] - Fosun Pharma has received clinical trial approval for its innovative drug FXS887, aimed at treating advanced malignant solid tumors, with no similar small molecule inhibitors approved globally [1] - Degu Technology has terminated its major asset restructuring plans due to failure to reach an agreement on key terms with the transaction counterparties [1] - Baiwei Storage's second-largest shareholder, the National Integrated Circuit Industry Investment Fund II, reduced its stake by 4.646 million shares, representing 0.9955% of the total share capital, from 7.9033% to 6.9078% [2] - Guizhou Bai Ling's actual controller, Jiang Wei, is under investigation by the China Securities Regulatory Commission for insider trading and other violations, which does not affect the company's operations [3] - Chalco International's subsidiary has won a bid for a 3.03 billion yuan electrolytic aluminum project, which is expected to positively impact the company's future performance [4] - Grinda plans to invest approximately 79.999 million yuan in a strategic placement of shares in Muxi Integrated Circuit, representing 0.19% of the total share capital post-IPO [5] - Wanlong Optoelectronics is planning to acquire control of Zhejiang Zhongkong Information Industry Co., which is expected to constitute a major asset restructuring [7]

歌礼制药-B(01672)发布公告，于2025年12月3日，该公司斥资1592.75万港元回购130.6万股股份，每股 回购价格为11.68-12.48港元。 ...